Compugen (CGEN) Revenue Growth (1y) (2010 - 2026)
Powered by 
Analysis
Compugen (CGEN) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 12.45% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 16.73% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 59.71% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.11% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 29.63% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 66.86% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 16.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 296.11% |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | 107.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.00% |
| Mar 31, 2026 | -4.73% |
| Dec 31, 2025 | 4,477.29% |
| Sep 30, 2025 | -88.96% |
| Jun 30, 2025 | -81.24% |
| Mar 31, 2025 | -10.75% |
| Dec 31, 2016 | -99.36% |
| Sep 30, 2016 | -69.43% |
| Jun 30, 2016 | 122.42% |
| Mar 31, 2016 | -81.87% |
| Dec 31, 2015 | 26.88% |
| Sep 30, 2015 | -86.67% |
| Jun 30, 2015 | -88.65% |
| Mar 31, 2015 | -75.95% |
| Dec 31, 2014 | 269.13% |
| Sep 30, 2014 | 8.05% |
| Jun 30, 2014 | 8,827.27% |
| Mar 31, 2014 | 1,216.67% |
| Dec 31, 2013 | 1,224.63% |
| Sep 30, 2013 | 1,372.22% |